Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Orland

Showing results (351-360 of 444) with videos related to

Pageof 45
Sort By:
Carcinogenesis|August 10, 2013
The highly prevalent BRCA2 mutation c.2808_2811del (3036delACAA) is located in a mutational hotspot and has multiple originsMar Infante, Mercedes Durán, Alberto Acedo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 10, 2019
Factors associated with sentinel lymph node status and prognostic role of completion lymph node dissection for thick melanomaAram Boada, Antonio Tejera-Vaquerizo, Simone Ribero, et al.
European Journal of Human Genetics : EJHG|November 29, 2022
An spanish study of secondary findings in families affected with mendelian disorders: choices, prevalence and family historyMarta Codina-Solà, Laura Trujillano, Anna Abulí, et al.
International Journal of Cancer|June 2, 2004
The variant E233G of the RAD51D gene could be a low-penetrance allele in high-risk breast cancer families without BRCA1/2 mutationsRaquel Rodríguez-López, Ana Osorio, Gloria Ribas, et al.
Plos One|August 13, 2013
Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer casesAna Blanco, Miguel de la Hoya, Ana Osorio, et al.
Breast Cancer Research and Treatment|July 20, 2011
Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium membersMads Thomassen, Ana Blanco, Marco Montagna, et al.
International Journal of Cancer|October 17, 2013
About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variantsSara Gutiérrez-Enríquez, Sandra Bonache, Gorka Ruíz de Garibay, et al.
Breast Cancer Research and Treatment|November 5, 2011
Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancerAna Blanco, Miguel de la Hoya, Judith Balmaña, et al.
Health Promotion and Chronic Disease Prevention in Canada : Research, Policy and Practice|August 22, 2022
The Royal Canadian Mounted Police (RCMP) Study: protocol for a prospective investigation of mental health risk and resilience factorsR Nicholas Carleton, Gregory P Krätzig, Shannon Sauer-Zavala, et al.
Nature Communications|March 8, 2018
Decapping protein EDC4 regulates DNA repair and phenocopies BRCA1Gonzalo Hernández, María José Ramírez, Jordi Minguillón, et al.
Pageof 45

Showing results (351-360 of 444) with videos related to

Sort By:
Pageof 45
Carcinogenesis|August 10, 2013
The highly prevalent BRCA2 mutation c.2808_2811del (3036delACAA) is located in a mutational hotspot and has multiple originsMar Infante, Mercedes Durán, Alberto Acedo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 10, 2019
Factors associated with sentinel lymph node status and prognostic role of completion lymph node dissection for thick melanomaAram Boada, Antonio Tejera-Vaquerizo, Simone Ribero, et al.
European Journal of Human Genetics : EJHG|November 29, 2022
An spanish study of secondary findings in families affected with mendelian disorders: choices, prevalence and family historyMarta Codina-Solà, Laura Trujillano, Anna Abulí, et al.
International Journal of Cancer|June 2, 2004
The variant E233G of the RAD51D gene could be a low-penetrance allele in high-risk breast cancer families without BRCA1/2 mutationsRaquel Rodríguez-López, Ana Osorio, Gloria Ribas, et al.
Plos One|August 13, 2013
Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer casesAna Blanco, Miguel de la Hoya, Ana Osorio, et al.
Breast Cancer Research and Treatment|July 20, 2011
Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium membersMads Thomassen, Ana Blanco, Marco Montagna, et al.
International Journal of Cancer|October 17, 2013
About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variantsSara Gutiérrez-Enríquez, Sandra Bonache, Gorka Ruíz de Garibay, et al.
Breast Cancer Research and Treatment|November 5, 2011
Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancerAna Blanco, Miguel de la Hoya, Judith Balmaña, et al.
Health Promotion and Chronic Disease Prevention in Canada : Research, Policy and Practice|August 22, 2022
The Royal Canadian Mounted Police (RCMP) Study: protocol for a prospective investigation of mental health risk and resilience factorsR Nicholas Carleton, Gregory P Krätzig, Shannon Sauer-Zavala, et al.
Nature Communications|March 8, 2018
Decapping protein EDC4 regulates DNA repair and phenocopies BRCA1Gonzalo Hernández, María José Ramírez, Jordi Minguillón, et al.
Pageof 45